CLOV

Clover Health Investments, Corp. Class A Common Stock

CLOV
Closed
$4.51
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. The company is headquartered in Jersey City, New Jersey and currently employs 724 full-time employees. The company went IPO on 2020-06-12. The firm is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
Country

US

CEO

Mr. Andrew Toy

IPO date

2020

Employees

724

ISIN

US18914F1030

Key stats

Open

$4.69

Volume

4.67M

Market cap

$2.46B

Prev. close

$4.68

Impl / hst vl

-

Open interest

$0.00

$4.34

Day’s Range

$4.75

$1.58

52W Range

$5.59

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
1.11
P/B
7.26
Current ratio
1.33
Debt / Equity
-0.51
ROE
-17.08%
Gross margin
-
Income growth
-155.42%
FCF growth
-255.70

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$3.62
The top 6 analysts forecasts that 12-month price may decrease by 19.71%, with a low of $1.77 and a high of $4.99
$1.77
Low
$3.62
Avg
$4.99
High
Current price

Earnings

Q1 ‘26 revenue
$749.19M
Q1 ‘26 net income
$27.33M
Revenue
Net income
Previous EPS
$0.07
Estimate EPS
$0.03
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply